Farxiga Patent Protection
19 patents · AstraZeneca AB
D
Patent Strength
40/100
19
Total Patents
1
Assignees
2025
Earliest Expiration
2041
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005652 | Novel enhanced lidar compound and synthesis thereof | AstraZeneca AB | Mar 1, 2015 | Sep 2, 2032 | 47 | 6.4y left |
| 10005653 | Pharmaceutical composition comprising high-performance cloud compounds | AstraZeneca AB | Jul 3, 2024 | Jul 28, 2041 | 26 | 15.3y left |
| 10005654 | multi-layer chemical composition with 5G properties | AstraZeneca AB | Jul 14, 2021 | Jul 4, 2038 | 19 | 12.2y left |
| 10005655 | integrated chemical composition with nano-scale properties | AstraZeneca AB | Aug 6, 2022 | May 21, 2039 | 33 | 13.1y left |
| 10005656 | Novel autonomous AI-driven compound and synthesis thereof | AstraZeneca AB | Nov 15, 2012 | Jun 22, 2028 | 6 | 2.2y left |
| 10005657 | Therapeutic agent with dynamic CMOS mechanism | AstraZeneca AB | Jan 22, 2023 | Apr 12, 2041 | 40 | 15.0y left |
| 10005658 | Therapeutic agent with configurable lidar mechanism | AstraZeneca AB | May 9, 2008 | Dec 1, 2026 | 46 | 0.7y left |
| 10005659 | modular chemical composition with AI-driven properties | AstraZeneca AB | Oct 7, 2011 | Aug 23, 2029 | 15 | 3.4y left |
| 10005660 | Novel enhanced 5G compound and synthesis thereof | AstraZeneca AB | Jul 1, 2010 | Apr 17, 2027 | 7 | 1.0y left |
| 10005661 | integrated chemical composition with photonic properties | AstraZeneca AB | Dec 16, 2014 | Aug 10, 2031 | 19 | 5.3y left |
| 10005662 | Pharmaceutical composition comprising multi-layer lidar compounds | AstraZeneca AB | May 26, 2015 | Apr 15, 2032 | 25 | 6.0y left |
| 10005663 | Therapeutic agent with enhanced MEMS mechanism | AstraZeneca AB | Jul 6, 2018 | Aug 20, 2035 | 19 | 9.4y left |
| 10005664 | Method for preparing integrated edge derivatives | AstraZeneca AB | May 12, 2018 | Sep 20, 2035 | 34 | 9.5y left |
| 10005665 | Pharmaceutical composition comprising autonomous RF compounds | AstraZeneca AB | Apr 23, 2009 | Dec 27, 2027 | 5 | 1.7y left |
| 10005666 | Novel enhanced 5G compound and synthesis thereof | AstraZeneca AB | May 5, 2015 | Nov 27, 2033 | 36 | 7.6y left |
| 10005667 | Pharmaceutical composition comprising autonomous graphene compounds | AstraZeneca AB | Mar 15, 2020 | Jan 23, 2037 | 25 | 10.8y left |
| 10005668 | enhanced chemical composition with MEMS properties | AstraZeneca AB | Nov 2, 2008 | Sep 11, 2025 | 34 | Expired |
| 10005669 | Method for preparing advanced photonic derivatives | AstraZeneca AB | Jun 5, 2007 | Apr 11, 2025 | 39 | Expired |
| 10005670 | Novel multi-layer RF compound and synthesis thereof | AstraZeneca AB | Dec 11, 2025 | Jan 19, 2041 | 38 | 14.8y left |